Leerink Partners cuts Caribou Biosciences target to $1.00
Leerink Partners reduced its price target on Caribou Biosciences to $1.00 per share from $4.00.
Story updates
12:13:35 PM UTC
SquawkNews
Caribou Biosciences Cut to Market Perform From Outperform by Leerink Partners